Further immunohistochemical staining of her 2023 colon cancer sample showed loss of expression of MSH2 protein and a very reduced expression of MSH6 protein, implying a germline mutation within MSH2, as MSH6 was unstable in the absence of MSH2. This evidence concerns the gene MSH6 and malignant colon neoplasm.